🔗 Share this article

An underground market for unlicensed slimming drugs is being driven by TikTok fitness influencers and vendors on communication apps, based on new investigations.

Investigational Drug Acquiring Popularity Via Social Media

The experimental drug, which is still in research studies, is being advertised by social media influencers for its alleged fat-burning properties. Followers are encouraged to message these accounts directly for supplier links, while also obtaining discount codes.

Thriving Trade on Social Networks

Separately, a robust market exists on messaging services, where communities with numerous of members share “before and after” photos, injection guides and claims of next-day British shipping. Sellers promote the drug there before directing customers to WhatsApp for purchases.

Learning About The Experimental Drug

Retatrutide is an experimental injectable created by American pharmaceutical company Eli Lilly. The drug targets three intestinal hormones – GLP-1, glucose-dependent insulinotropic polypeptide and glucagon. Early trials suggest it could assist patients lose up to 25% of their total weight. Referred to as the “triple G”, the substance is being promoted digitally as the next Ozempic.

Healthcare Professionals Voice Concerns

Nevertheless, physicians and pharmacists have cautions that the distribution of what is still an unlicensed medication in the UK is worrisome and could lead to users administering products of unknown origin.

Some professionals said the popularity for retatrutide could be connected to the increasing price of approved weight loss products such as Mounjaro.

Regulatory Position and Enforcement

Marketing retatrutide on social media or Telegram is illegal in the UK, as it is an unlicensed drug that cannot be promoted or supplied for personal consumption under the British medical regulations.

Several influencers attempt to sidestep the regulations by calling to the substance as a “research chemical” or describing it as “not for human consumption”. The substance is not a controlled drug, but promotion and supply can still violate pharmaceutical, marketing, and customer laws, risking penalties, legal action or imprisonment.

Service Response and Content Removal

According to the social media company, the service has taken down problematic content and prohibited associated hashtags and query recommendations. The organization stated it was committed to keeping the service secure and allocating resources in enhancing compliance measures.

Digital Trading Operations

Investigations also found communities with up to 9,000 members selling the experimental drug using Telegram's built-in search feature, which functions like a public directory. Entering “retatrutide” instantly displays groups with numerous of members, filled with images of weight loss, glowing reviews and detailed guides for mixing or administering at residence.

After moments of joining one group, a seller shared contact information, where most transactions occur. The vendor provided an guidebook and guaranteed delivery within two days. When questioned whether the product was authentic, one vendor responded: “You can’t be sure.” Another provided a image of a alleged laboratory certificate. Not one asked about weight, health issues or past usage.

Item Information and Costs

Within these groups, messages display dark colored packages with postal service stickers, stating to include fresh supplies. One message stated: “It took eight of us to load them this morning.”

Customers can choose between powder vials, mixed at home with sterile water, or ready-to-use injectors usually priced at £160 for 20mg. When questioned how long a pen should be used, sellers give contradictory answers ranging from a several days to “depends on your body”.

Platform Moderation and Safety Measures

A representative for the messaging service stated it actively moderated harmful content on its service including content that encouraged the “misuse of controlled medications”. The organization noted that it removed “millions of pieces of harmful content each day”.

Medical Expert Cautions

“People are injecting substances they cannot confirm. Even if the research behind retatrutide is sound, these digital products may not include what they claim,” said Jason Murphy, the head of pharmaceutical services at Chemist4U.

Dr Crystal Wyllie of Asda Online Doctor linked the increase in demand to recent cost increases for approved slimming drugs such as Mounjaro. “With prices increasing, patients are turning to social media. But counterfeit injections are extremely dangerous. You can’t be certain what’s inside or whether the environment they were made in was clean,” she said.

Her team has already encountered patients harmed by personal administration from unverified suppliers. “We recognize the frustration, but buying from messaging apps or WhatsApp is gambling with your well-being,” stated Wyllie. “These substances could be contaminated or improperly measured.”

Manufacturer Statement

A spokesperson from the pharmaceutical company said retatrutide was in third stage research studies and had not been evaluated or approved by any regulatory agency globally. “Therefore at this point no one can sell [it] for human use,” they explained, noting that any item “misleadingly claiming itself as a company investigational product not yet approved … may expose users to possibly significant health risks”.